<DOC>
	<DOCNO>NCT02219360</DOCNO>
	<brief_summary>Chronic obstructive pulmonary disease become serious global health care public health problem due high prevalence , high morbidity heavy economic burden . Acute exacerbation chronic obstructive pulmonary disease one important cause death patient COPD . Systemic corticosteroid therapy recommend COPD exacerbation . In clinical practice treatment acute exacerbation COPD， antibiotic application still controversial . Evidence current guideline base strict criterion randomize controlled trial , thus give condition simplify . Patients meet criterion account minority real world . Therefore , still clear whether patient benefit recommended treatment . In design , hospitalized patient acute exacerbation COPD enrol , treatment , arterial hypoxemia , recovery time length hospitalization observe . The main purpose evaluate benefit effect current recommend treatment acute exacerbation COPD real world .</brief_summary>
	<brief_title>Treatment Patients Hospitalized With Acute Exacerbation Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description>Chronic obstructive pulmonary disease become serious global health care public health problem due high prevalence , high morbidity heavy economic burden . Acute exacerbation COPD one important cause death patient COPD . The global strategy diagnosis , management , prevention COPD recommend systemic corticosteroid therapy COPD exacerbation shorten recovery time , reduce treatment failure , improve lung function arterial hypoxemia . In clinical practice treatment acute exacerbation COPD， antibiotic application still controversial . Evidence current guideline base strict criterion randomize controlled trial , thus give condition simplify . Patients meet criterion account minority real world . Therefore , still clear whether patient benefit recommended treatment . In design , hospitalized patient acute exacerbation COPD enrol , treatment , arterial hypoxemia , recovery time length hospitalization observe . The main purpose evaluate benefit effect current recommend treatment acute exacerbation COPD real world .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Hospitalized patient acute exacerbation chronic obstructive pulmonary disease Age≥ 40years old The first diagnosis cause hospitalization acute exacerbation chronic obstructive pulmonary disease Chest radiography show congestive heart failure Chest CT show lung cancer , active pulmonary tuberculosis , pulmonary thromboembolism interstitial lung diseases Serious cardiac failure , renal insufficiency hepatic dysfunction</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>acute</keyword>
	<keyword>exacerbation</keyword>
	<keyword>chronic obstructive pulmonary disease</keyword>
</DOC>